Related Experiment Videos

Type 1 diabetes intervention trials: what have we learned? A critical review of selected intervention trials

Carla J Greenbaum1

  • 1Diabetes Clinical Research, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101, USA. cjgreen@vmresearch.org

Clinical Immunology (Orlando, Fla.)
|August 8, 2002
PubMed

Insights

Developing type 1 diabetes therapies to halt islet destruction remains challenging. Study design variations significantly influence treatment outcomes, necessitating standardized trial guidelines for future research.

Area of Science:

  • Immunology
  • Endocrinology
  • Clinical Trials

Background:

  • Type 1 diabetes involves autoimmune destruction of pancreatic islets.
  • Decades of research aim to develop therapies to prevent or slow this immune process.

Purpose of the Study:

  • To review clinical interventions for type 1 diabetes.
  • To analyze the impact of study design on therapeutic outcomes.

Main Methods:

  • Review of existing clinical intervention studies in type 1 diabetes patients.
  • Analysis of reported outcomes in relation to therapeutic agents and study design variables.

Main Results:

  • Clinical interventions have shown mixed results, with both positive and negative outcomes.
  • Differences in study design appear to be a major factor influencing observed treatment effects, potentially overshadowing the therapy itself.

Conclusions:

  • Current evidence does not definitively establish the optimal study design for evaluating type 1 diabetes therapies.
  • Standardized trial guidelines, such as those recently developed by the Immunology of Diabetes Society, are crucial for future research and comparative analysis of interventions.

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...